• P. N. Patsalos


Lacosamide (Fig. 1) corresponds chemically to (R)-2-acetamido-N-benzyle-3-methoxypropramide with an empirical formula of C13H18N2O3 and a molecular weight of 250.29.


Valproic Acid Antiepileptic Drug Empirical Formula Therapeutic Drug Monitoring Drug Monitoring 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1. 
    Cawello W, Nickel B, Eggert-Formella A. No pharmacokinetic interaction between lacosamide and carbamazepine in healthy volunteers. J Clin Pharmacol. 2010;50:459–71.PubMedCrossRefGoogle Scholar
  2. 2. 
    Novy J, Patsalos PN, Sander JW, Sisodiya SM. Lacosamide neurotoxicity associated with concomitant use of sodium-blocking antiepileptic drugs: a pharmacodynamic interaction? Epilepsy Behav. 2011;20:20–3.PubMedCrossRefGoogle Scholar
  3. 3. 
    Thomas D, Scharfenecker U, Schiltmeyer B, Doty P, Cawello W, Horstmann R. Low potential for drug-drug interactions of lacosamide. Epilepsia. 2006;47 (Suppl 4):200.Google Scholar
  4. 4. 
    Nickel B, Zisowsky J, Cawello W, Lovern M, Sargentini-Maier ML. Population pharmacokinetics of LCM in subjects with partial-onset seizures: Results from two Phase III trials. J Clin Pharmacol. 2008;48: 1129.Google Scholar
  5. 5. 
    Cawello W, Bonn R. No pharmacokinetic interaction between lacosamide and valproic acid in healthy volunteers. J Clin Pharmacol. 2012;52:1739–48.Google Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • P. N. Patsalos
    • 1
    • 2
  1. 1.UCL-Institute of Neurology Department of Clinical and Experimental EpilepsyLondonLondon
  2. 2.Epilepsy Society Chalfont Centre for EpilepsyBuckinghamshireUK

Personalised recommendations